DK0814077T3 - Benzoylguanidiner, fremgangsmåde til deres fremstilling samt lægemidler med indhold heraf - Google Patents

Benzoylguanidiner, fremgangsmåde til deres fremstilling samt lægemidler med indhold heraf

Info

Publication number
DK0814077T3
DK0814077T3 DK97109546T DK97109546T DK0814077T3 DK 0814077 T3 DK0814077 T3 DK 0814077T3 DK 97109546 T DK97109546 T DK 97109546T DK 97109546 T DK97109546 T DK 97109546T DK 0814077 T3 DK0814077 T3 DK 0814077T3
Authority
DK
Denmark
Prior art keywords
benzoylguanidines
processes
preparation
pharmaceuticals containing
pharmaceuticals
Prior art date
Application number
DK97109546T
Other languages
Danish (da)
English (en)
Inventor
Dr Weichert Andreas
Dr Brendel Joachim
Dr Kleemann Heinz-Werner
Jochen Dr Lang Hans
Dr Schwark Jan-Robert
Dr Albus Udo
Dr Scholz Wolfgang
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0814077T3 publication Critical patent/DK0814077T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK97109546T 1996-06-18 1997-06-12 Benzoylguanidiner, fremgangsmåde til deres fremstilling samt lægemidler med indhold heraf DK0814077T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19624178A DE19624178A1 (de) 1996-06-18 1996-06-18 Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
DK0814077T3 true DK0814077T3 (da) 2000-08-14

Family

ID=7797197

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97109546T DK0814077T3 (da) 1996-06-18 1997-06-12 Benzoylguanidiner, fremgangsmåde til deres fremstilling samt lægemidler med indhold heraf

Country Status (31)

Country Link
US (1) US6001881A (no)
EP (1) EP0814077B1 (no)
JP (1) JP3977897B2 (no)
KR (1) KR100498799B1 (no)
CN (1) CN1064676C (no)
AR (1) AR012536A1 (no)
AT (1) ATE191469T1 (no)
AU (1) AU711734B2 (no)
BR (1) BR9703617A (no)
CA (1) CA2207886A1 (no)
CZ (1) CZ291848B6 (no)
DE (2) DE19624178A1 (no)
DK (1) DK0814077T3 (no)
ES (1) ES2146049T3 (no)
GR (1) GR3033299T3 (no)
HR (1) HRP970332B1 (no)
HU (1) HUP9701057A3 (no)
ID (1) ID17321A (no)
IL (1) IL121085A0 (no)
MX (1) MX9704486A (no)
MY (1) MY117304A (no)
NO (1) NO307928B1 (no)
NZ (1) NZ328100A (no)
PL (1) PL185756B1 (no)
PT (1) PT814077E (no)
RU (1) RU2193025C2 (no)
SI (1) SI0814077T1 (no)
SK (1) SK282351B6 (no)
TR (1) TR199700508A2 (no)
TW (1) TW374759B (no)
ZA (1) ZA975312B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19608161A1 (de) * 1996-03-04 1997-09-11 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19713427A1 (de) * 1997-04-01 1998-10-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10001879A1 (de) 2000-01-19 2001-07-19 Aventis Pharma Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6641811B1 (en) * 2000-02-10 2003-11-04 Cornell Research Foundation, Inc. Use of angiotensin II inhibitors to prevent malignancies associated with immunosuppression
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4430213A1 (de) * 1994-08-28 1996-02-29 Merck Patent Gmbh Arylbenzoylguanidine
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE19608162A1 (de) * 1996-03-04 1997-09-11 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
JPH1067733A (ja) 1998-03-10
HRP970332B1 (en) 2001-02-28
MY117304A (en) 2004-06-30
HU9701057D0 (en) 1997-08-28
ATE191469T1 (de) 2000-04-15
NZ328100A (en) 1998-09-24
AU711734B2 (en) 1999-10-21
MX9704486A (es) 1997-12-31
NO307928B1 (no) 2000-06-19
GR3033299T3 (en) 2000-09-29
ZA975312B (en) 1998-01-05
DE59701388D1 (de) 2000-05-11
PL320326A1 (en) 1997-12-22
KR980002020A (ko) 1998-03-30
KR100498799B1 (ko) 2005-12-16
TW374759B (en) 1999-11-21
HUP9701057A3 (en) 2000-08-28
CZ291848B6 (cs) 2003-06-18
ES2146049T3 (es) 2000-07-16
EP0814077A1 (de) 1997-12-29
HUP9701057A2 (hu) 1998-12-28
EP0814077B1 (de) 2000-04-05
IL121085A0 (en) 1997-11-20
CN1169987A (zh) 1998-01-14
PL185756B1 (pl) 2003-07-31
SK282351B6 (sk) 2002-01-07
JP3977897B2 (ja) 2007-09-19
SI0814077T1 (en) 2000-08-31
RU2193025C2 (ru) 2002-11-20
BR9703617A (pt) 1998-09-29
CA2207886A1 (en) 1997-12-18
AR012536A1 (es) 2000-11-08
CZ188797A3 (cs) 1998-05-13
US6001881A (en) 1999-12-14
TR199700508A2 (xx) 1998-01-21
NO972793D0 (no) 1997-06-17
CN1064676C (zh) 2001-04-18
ID17321A (id) 1997-12-18
DE19624178A1 (de) 1998-01-08
SK76697A3 (en) 1998-01-14
HRP970332A2 (en) 1998-04-30
PT814077E (pt) 2000-07-31
NO972793L (no) 1997-12-19
AU2494297A (en) 1998-01-08

Similar Documents

Publication Publication Date Title
DK0927192T3 (da) Modificerede aminosyrer, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
NO952618L (no) Xerogeler, fremgangsmåte for fremstilling derav samt deres anvendelse
DK0815130T3 (da) Caseinphosphopeptid, casein indeholdende samme og fremgangsmåde til præparationen deraf
DK316189A (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
NO308287B1 (no) Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse
DK0562583T3 (da) Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf
DK0840548T3 (da) Synergistisk, herbicid sammensætning samt fremgangsmåde til fremstilling deraf
DK1015421T3 (da) Nye phenylamidinderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler
DK1015433T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oler, fremgangsmåder til fremstilling af disse og deres anvendelse som lægemidler
DK0793645T3 (da) Iminooxymethylenanilider, fremgangsmåder og mellemprodukter til deres fremstilling, samt pesticider, der indeholder dem
NO20003661L (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
DK0842927T3 (da) 3-Amido-chromanylsulfonyl(thio)urinstoffer, fremgangsmåder til deres fremstilling, deres anvendelse og farmaceutiske præparater med indhold deraf
NO308362B1 (no) 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene
NO963487D0 (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
NO165639C (no) Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling, og deres anvendelse.
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
DK0814077T3 (da) Benzoylguanidiner, fremgangsmåde til deres fremstilling samt lægemidler med indhold heraf
DK0726250T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåder til deres fremstilling og deres anvendelse til
DK0931088T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DK178589A (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK0754680T3 (da) 4-Fluoralkyl-substituerede benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
FI951806A0 (fi) Radiosystem som utgoer en traodloes abonnentanslutning samt en abonnentapparat
NO20002483D0 (no) Nye 19-nor-steroider substituert i posisjon 11B, fremgangsmÕte for fremstilling av slike samt mellomprodukter, deres anvendelse som medisiner, og farmasøytiske preparater inneholdende disse
NO992209D0 (no) Nye Knoevenagel-kondensasjonsprodukter, fremgangsmÕte for deres fremstilling samt anvendelse derav